Article
High CD4‐to‐CD8 ratio identifies an at‐risk population susceptible to lethal COVID‐19
3 Dec 2021
Abstract excerpt
Around half of people with severe COVID-19 requiring intensive care unit (ICU) treatment will survive, but it is unclear how the immune response to SARS-CoV-2 differs between ICU patients that recover and those that do not. We conducted whole-blood immunophenotyping of COVID-19 patients upon admission to ICU and during their treatment and uncovered marked differences in their circulating immune cell subsets. At...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
